DONATE →
Silvia Masini
2025 call AI / Imaging

Dr. Silvia Masini

Oncology researcher (scientific coordination by Prof. Armando Santoro)

📍 Humanitas Research Hospital, Milano

Grant received: €3.000
AI-Imaging

Generative Adversarial Networks (GANs) applied to diagnostic imaging in lung oncology

Developing artificial intelligence models (GANs) to improve diagnostic imaging in lung cancer, focusing on early prediction and risk stratification. Project coordinated by Prof. Armando Santoro at Humanitas.

Update

Project update

The project is in the phase of collecting and harmonising clinical data from two retrospective cohorts of NSCLC patients treated with chemo-immunotherapy and immunotherapy. The database will soon be shared with the AI Center to generate and validate synthetic data using artificial intelligence models; in parallel, patient enrolment in the prospective validation cohort and coordination of the liquid biopsy have begun. Data cleaning and the structuring of the final database are currently being completed before the transfer to the AI Center; the development of generative models and the comparison between real and synthetic data for statistical reliability and clinical usefulness will follow.

«This funding is a crucial step in turning real-world clinical data into innovative tools for cancer research. It will allow us to develop the project and to share future results in international scientific settings.»

— Silvia Masini
Scientific abstract

Clinical and Biomarker-Based Predictors of Outcomes in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Checkpoint Inhibitors With or Without Platinum-Based Chemotherapy

Overall objective

To generate adequate synthetic data from a real-world cohort of well-annotated consecutive lung cancer patients using GANs and other generative models, and to validate the generated synthetic data with a validation framework in terms of statistical fidelity, clinical utility and privacy preservability.

Expected results

We expect to generate high-fidelity synthetic datasets that reliably reproduce the statistical distribution and clinical complexity of real-world NSCLC cohorts. Validated through the SAFE and MOSAIC frameworks, the models will demonstrate an improved ability to predict outcomes in first-line immunotherapy, while ensuring robust privacy preservation and enabling secure data sharing.

Project key data

Formal title
Clinical and Biomarker-Based Predictors of Outcomes in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Checkpoint Inhibitors With or Without Platinum-Based Chemotherapy
Expected duration
24 months
Funding
€3.000
Research centre
IRCCS Humanitas Research Hospital

Details

Call edition
Strongers for Research 2025
Awarded on
31 March 2026
Source
2025 call — award notified 31/03/2026

Fund the next researcher

Every €3,000 raised = one more grant in the next call. You run, you donate, they do research.

Donate now See the open call
← All funded researchers